Coronary Artery Disease (CAD)

Onyx Frontier Drug-Eluting Stent Receives FDA Approval for CAD

May 13, 2022

Announced on May 13, the Onyx Frontier DES carries the same clinical indications as Medtronic's Resolute Onyx DES and will be available in 2.0 mm sizes as well as 4.50-5.00 mm sizes that can be expanded to 6.00 mm.

Cardiac CT Provides Reliable, Noninvasive Alternative to Angiography in Diagnosing Coronary Artery Disease

March 05, 2022

Data from the DISCHARGE trial provides evidence demonstrating computed tomography could be a safe alternative to catheterization in patients with stable chest pain and suspected CAD.

Gestational Diabetes Increases Long-Term Risk for Wide Array of Cardiovascular Conditions

February 07, 2022

Analysis of the UK Biobank cohort suggests presence of gestational diabetes was associated with a 33% increase in risk of CAD, 67% increase in risk of myocardial infarction, 69% increase in risk of stroke, and 42% increase in risk heart failure.

AHA Study Evaluates Predictors of Negative Outcomes in Stable CAD

November 21, 2021

An analysis of nearly 1000 patients from Spain is providing clinicians with insight into factors that could help predict negative outcomes among patients with stable coronary artery disease.

REDUCE-IT PAD: Icosapent Ethyl Provides Consistent Benefit in PAD Patients

November 13, 2021

Deepak Bhatt, MD, MPH, provides perspective on the results of the REDUCE-IT PAD analysis he presented at the American Heart Association 2021 Scientific Sessions.

Is Silence Golden? The Hunt for Hardening of the Arteries

October 22, 2021

Arnold Meshkov, MD, explores how discoveries and the advent of new technologies have influenced diagnosis of atherosclerosis throughout history.

Functional Iron Deficiency Linked to Increased Risk of Coronary Heart Disease, Cardiovascular Mortality

October 08, 2021

Leveraging data from 3 European cohorts, investigators detail the risk of incident coronary heart disease and mortality associated with iron deficiency in the general population.

Addition of Low-Dose Rivaroxaban to Algorithms Could Provide Benefit in CAD/PAD

July 10, 2021

An analysis of data from the COMPASS study suggests the addition of low-dose rivaroxaban to aspirin resulted in benefits, irrespective of concomitant therapies or comorbidities.

More than 20% of CAD Patients Report Monthly Episodes of Angina

June 14, 2021

A cross-sectional analysis of data suggests more than 20% of patients with coronary artery disease report experiencing angina at least once a month while 12.5% report experiencing angina daily or weekly.

Women Who Experience Premature Menopause at Increased Risk of Coronary Heart Disease

May 27, 2021

An analysis of data from 10k women in the Lifetime Risk Pooling Project presented at EPI Lifestyle 2021 suggests premature menopause was associated with a 40% increase in risk of coronary heart disease.